Novartis Ag (NVS) Debt Ratio (2009 - 2026)
Novartis Ag's (NVS) quarterly Debt Ratio came in at 0.08 in Q2 2026, down 1.34% year-over-year from 0.08 in Q2 2025, and up 22.27% quarter-over-quarter from 0.06 in Q1 2026.
Analysis
Novartis Ag (NVS) Debt Ratio (2009 - 2026) Analysis & Trends
Novartis Ag has disclosed Debt Ratio across 18 years of filings, most recently posting 0.08 for Q2 2026.
- In Q2 2026, Debt Ratio fell 1.34% year-over-year to 0.08; the TTM figure through Jun 2026 stood at 0.08 (down 1.34% YoY), while the FY2025 annual figure was 0.06, down 34.74% from the prior year.
- Debt Ratio came in at 0.08 for Q2 2026 at Novartis Ag, up from 0.06 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.09 in Q1 2024 to a low of 0.05 in Q3 2023.
- Average Debt Ratio over 5 years is 0.07, with a median of 0.07 recorded in 2023.
- Year-over-year, Debt Ratio plunged 35.95% in 2022 and soared 42.39% in 2024.
- Over 5 years, Debt Ratio stood at 0.06 in 2022, then increased by 17.6% to 0.07 in 2023, then climbed by 27.58% to 0.09 in 2024, then tumbled by 34.74% to 0.06 in 2025, then surged by 38.72% to 0.08 in 2026.
- Per Business Quant data, the three most recent Debt Ratio figures were 0.08 in Q2 2026, 0.06 in Q1 2026, and 0.06 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 0.30 |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 0.08 |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 0.31 |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 0.17 |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 0.00 |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | - |
| 10 | Jazz Pharmaceuticals | 16.02 Bn | 14.40 Bn | 1.09 Bn | 0.48 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.08 |
| Mar 31, 2026 | 0.06 |
| Dec 31, 2025 | 0.06 |
| Sep 30, 2025 | 0.07 |
| Jun 30, 2025 | 0.08 |
| Mar 31, 2025 | 0.08 |
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | 0.06 |
| Jun 30, 2024 | 0.08 |
| Mar 31, 2024 | 0.09 |
| Dec 31, 2023 | 0.07 |
| Sep 30, 2023 | 0.05 |
| Jun 30, 2023 | 0.07 |
| Mar 31, 2023 | 0.06 |
| Dec 31, 2022 | 0.06 |
| Sep 30, 2022 | 0.06 |
| Jun 30, 2022 | 0.06 |
| Mar 31, 2022 | 0.05 |
| Dec 31, 2021 | 0.05 |
| Sep 30, 2021 | 0.08 |